Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (161-170 of 241) with videos related to

Pageof 25
Sort By:
Emerging Microbes & Infections|November 27, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2021
Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patientLawrence J Purpura, Michelle Chang, Medini K Annavajhala, et al.
Vaccine|July 5, 2005
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusPatrick C Y Woo, Susanna K P Lau, Hoi-Wah Tsoi, et al.
Cell Reports|April 1, 2021
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody classMicah Rapp, Yicheng Guo, Eswar R Reddem, et al.
The Lancet. Infectious Diseases|November 3, 2022
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisationQian Wang, Zhiteng Li, Jerren Ho, et al.
Emerging Microbes & Infections|November 10, 2022
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2Mengxiao Luo, Biao Zhou, Eswar R Reddem, et al.
Emerging Microbes & Infections|September 15, 2020
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe diseasePengfei Wang, Lihong Liu, Manoj S Nair, et al.
Cell Host & Microbe|April 22, 2020
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgAManxue Jia, Rachel A Liberatore, Yicheng Guo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2015
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1Marion Morgand, Mélanie Bouvin-Pley, Jean-Christophe Plantier, et al.
Pageof 25

Showing results (161-170 of 241) with videos related to

Sort By:
Pageof 25
Emerging Microbes & Infections|November 27, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2021
Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patientLawrence J Purpura, Michelle Chang, Medini K Annavajhala, et al.
Vaccine|July 5, 2005
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusPatrick C Y Woo, Susanna K P Lau, Hoi-Wah Tsoi, et al.
Cell Reports|April 1, 2021
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody classMicah Rapp, Yicheng Guo, Eswar R Reddem, et al.
The Lancet. Infectious Diseases|November 3, 2022
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisationQian Wang, Zhiteng Li, Jerren Ho, et al.
Emerging Microbes & Infections|November 10, 2022
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2Mengxiao Luo, Biao Zhou, Eswar R Reddem, et al.
Emerging Microbes & Infections|September 15, 2020
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe diseasePengfei Wang, Lihong Liu, Manoj S Nair, et al.
Cell Host & Microbe|April 22, 2020
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgAManxue Jia, Rachel A Liberatore, Yicheng Guo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2015
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1Marion Morgand, Mélanie Bouvin-Pley, Jean-Christophe Plantier, et al.
Pageof 25